Felix Gerhardt
Overview
Explore the profile of Felix Gerhardt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
356
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yogeswaran A, Grimminger J, Tello K, Becker L, Seeger W, Grimminger F, et al.
Pulm Circ
. 2024 Aug;
14(3):e12397.
PMID: 39105131
The PEGASUS study is the first multicentric and prospective assessment of the safety of air travel flying in pulmonary hypertension (PH) (NCT03051763). Data of air travel from 60 patients with...
2.
Wissmuller M, Wartner V, Hohmann C, Adler J, Kramer T, Hellmich M, et al.
Eur Respir J
. 2024 May;
63(5).
PMID: 38754949
No abstract available.
3.
Gerhardt F, Fiessler E, Olsson K, Kayser M, Kovacs G, Gall H, et al.
Circulation
. 2024 Apr;
149(20):1549-1564.
PMID: 38606558
Background: Among patients with pulmonary arterial hypertension (PAH), acute vasoreactivity testing during right heart catheterization may identify acute vasoresponders, for whom treatment with high-dose calcium channel blockers (CCBs) is recommended....
4.
Kramer T, Nattmann P, Gerhardt F, Stafiej P, Dumitrescu D, Freyhaus H, et al.
ESC Heart Fail
. 2024 Jan;
11(3):1540-1552.
PMID: 38224960
Aims: In pulmonary arterial hypertension (PAH), upfront combination therapy with ERA and PDE5i is associated with a reduction in morbidity and mortality events and improves standard haemodynamics, but data remain...
5.
Gertz R, Gerhardt F, Pienn M, Lennartz S, Kroger J, Caldeira L, et al.
Eur Radiol
. 2023 Nov;
34(5):2944-2956.
PMID: 37921925
Objectives: To evaluate dual-layer dual-energy computed tomography (dlDECT)-derived pulmonary perfusion maps for differentiation between acute pulmonary embolism (PE) and chronic thromboembolic pulmonary hypertension (CTEPH). Methods: This retrospective study included 131...
6.
Wissmuller M, Wartner V, Hohmann C, Adler J, Kramer T, Hellmich M, et al.
Eur Respir J
. 2023 Oct;
62(4).
PMID: 37827573
No abstract available.
7.
Pienn M, Gertz R, Gerhardt F, Kroger J, Zaytoun H, Reimer R, et al.
J Heart Lung Transplant
. 2023 Aug;
43(1):54-65.
PMID: 37619642
Background: While computed tomography pulmonary angiography (CTPA) is an integral part of the work-up in patients with suspected pulmonary hypertension (PH), there is no established CTPA-derived prognostic marker. We aimed...
8.
Barco S, Mavromanoli A, Kreitner K, Bunck A, Gertz R, Ley S, et al.
Chest
. 2023 Jan;
163(4):923-932.
PMID: 36621756
Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is considered a complication of pulmonary embolism (PE). However, signs of CTEPH may exist in patients with a first symptomatic PE. Research Question: Which...
9.
Wissmuller M, Xanthouli P, Benjamin N, Grunig E, Richter M, Gall H, et al.
ESC Heart Fail
. 2022 Jun;
9(5):2873-2885.
PMID: 35706353
Aims: Guideline recommendations highlight the critical role of combination therapy for the treatment of pulmonary arterial hypertension (PAH). Conversely, registry data demonstrate that a considerable number of PAH patients remain...
10.
Valerio L, Mavromanoli A, Barco S, Abele C, Becker D, Bruch L, et al.
Eur Heart J
. 2022 Apr;
43(36):3387-3398.
PMID: 35484821
Aims: To systematically assess late outcomes of acute pulmonary embolism (PE) and to investigate the clinical implications of post-PE impairment (PPEI) fulfilling prospectively defined criteria. Methods And Results: A prospective...